Our approach
AI-powered drug discovery
We built K Pro, an AI scientist powered by multimodal patient data and advanced AI skills to drive smarter drug discovery for biopharma.



What we do
We combine powerful biological LLMs, multimodal patient data and over a decade of biomedical AI tools and expertise into a single AI Scientist, K Pro.
Context
Drug discovery is becoming slower and more expensive over time
$2.7Bn
Median cost of bringing an oncology or immunology drug to market
>13yrs
Time to bring a drug to market
90%
High attrition rate results in only 10% of drugs reaching the market
Challenges
We need better drugs, better targets, and better clinical trials
Challenge 1
Targets don’t convert to drugs
- Patient data is underutilized
- Pre-clinical models lack translatability to human biology
- Disease heterogeneity is not captured
Challenge 2
Drug responses vary between patients
- Lack understanding of tumor microenvironment
- Lack understanding of drug mechanism of action
- Incomplete knowledge of clinical heterogeneity
Owkin's solution
K Pro, the AI scientist for biology
K Pro is powered by multimodal patient data and advanced AI skills for smarter biopharma decision making.
It continuously learns from real-world data, user feedback, and clinical validation. The first agent to connect research to care.
Example Use Cases
Discover how K Pro powers smarter pipeline decisions
K Pro's flexible architecture means it can tackle your specific challenges, even ones we haven't anticipated yet.
Ready to get started?
Discover how K Pro can transform your drug discovery and development. Connect with our team to explore how we can support your specific needs.


